None listed
Conditions
Interventions
Trail group:NA
Sponsors
The First Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Referring to the research on biological variation by the European Federation of Clinical Chemistry and Laboratory Medicine [16], volunteers must meet all of the following criteria: 1. Agree to and sign the informed consent form. 2. Have been in a good subjective mood recently and have a high acceptance of the study. 3. Be over 18 years old. 4. Ideally, should not take any medications. Any volunteers who are taking medications or vitamin supplements must report the names, doses, and frequencies of the active substances therein and have them recorded by the researchers so that these individuals can be identified in the later stage. 5. Ideally, should not smoke or drink. Any volunteers who smoke or drink must report the types, quantities, and frequencies of smoking or drinking.
Exclusion criteria
Exclusion criteria: Volunteers will be excluded from the study if they meet any of the following conditions: 1. Known diabetes and undergoing oral or insulin treatment as prescribed, or having a fasting blood glucose level > 7.0 mmol/L. 2. A history of chronic liver or kidney diseases (?-glutamyl transferase > 150 U/L; estimated glomerular filtration rate (eGFR) 6.5 mmol/L). 4. A family history of thalassemia syndrome and other hemoglobinopathies. 5. Suffering from severe chronic diseases (cancer, cardiovascular or nervous system diseases) or acute diseases. 6. Known to be carriers of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). 7. A history of hospitalization or other serious diseases within the past 4 weeks. 8. Having donated blood without compensation within the recent 3 months. 9. Women who are pregnant, breastfeeding or within 1 year after childbirth. 10. Assessed by the researchers as being unfit for this study (such as having a history of fainting at the sight of blood, hemophilia and other diseases).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| White Blood Cell Count;Red Blood Cell Count;Hemoglobin;Platelet Count;Hematocrit;Mean Corpuscular Volume;Mean Corpuscular Hemoglobin Content;Mean Corpuscular Hemoglobin Concentration; Absolute Neutrophil Count;Neutrophil percentage;Absolute Lymphocyte Count;Lymphocyte Percentage;Absolute Monocyte Count;Monocyte Percentage;Absolute Eosinophil Count;Eosinophil Percentage;Absolute Basophil Count;Basophil Percentage;Alanine Aminotransferase;Aspartate Aminotransferase;Gamma - Glutamyl Transpeptidase;Alkaline Phosphatase;Uric Acid;Urea;Total Cholesterol;Triglyceride;High Density Lipoprotein;Low Density Lipoprotein;Blood Glucose; | — |
Countries
China
Contacts
Public ContactZeng Qinglei
The First Affiliated Hospital of Zhengzhou University
Outcome results
None listed